These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2145699)

  • 1. Eicosanoids and hypertension.
    Brater DC
    West J Med; 1990 Aug; 153(2):194-5. PubMed ID: 2145699
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins, the kidney, and hypertension.
    Wilson TW; Kaushal RD; Dubois M
    West J Med; 1990 Aug; 153(2):168-72. PubMed ID: 2219874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eicosanoid receptor and signal transduction].
    Nakamura M; Shimizu T
    Nihon Rinsho; 1990 Jun; 48(6):1129-33. PubMed ID: 2166838
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of eicosanoids inhibitors and thromboxane receptor antagonists in human glomerular disease.
    Cinotti GA
    Contrib Nephrol; 1989; 70():121-7. PubMed ID: 2527730
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboxane-receptor antagonist in renal transplantation.
    Ahonen J; Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; Häyry P; McAllister A
    Transplant Proc; 1990 Aug; 22(4):1370. PubMed ID: 2143856
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia.
    Askari B; Bell-Quilley CP; Fulton D; Quilley J; McGiff JC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):101-7. PubMed ID: 9223545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dietary lipids and renal eicosanoids on the progression of renal disease.
    Klahr S; Harris K
    Kidney Int Suppl; 1989 Nov; 27():S27-31. PubMed ID: 2699998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of renal prostaglandin metabolism in therapy of lupus nephritis.
    Cole EH
    J Rheumatol; 1996 Oct; 23(10):1686-8. PubMed ID: 8895140
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane receptor blockade in an animal model of ARDS.
    Wisner D; Sturm J; Sutter G; Ellendorf B; Nerlich M
    Surgery; 1988 Jul; 104(1):91-7. PubMed ID: 2968672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 11. Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.
    Rampton DS; Collins CE
    Aliment Pharmacol Ther; 1993 Aug; 7(4):357-67. PubMed ID: 8218751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and eicosanoid interactions in kidneys of Lyon hypertensive rats.
    Zhang BL; Liu KL; Benzoni D; Sassard J
    J Hypertens Suppl; 1993 Dec; 11(5):S136-7. PubMed ID: 8158313
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension correlated to pulmonary thromboxane synthesis.
    Frölich JC; Ogletree M; Peskar BA; Brigham KL
    Adv Prostaglandin Thromboxane Res; 1980; 7():745-50. PubMed ID: 7369039
    [No Abstract]   [Full Text] [Related]  

  • 15. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 16. Exaggerated prostaglandin and thromboxane synthesis in the renal vein constricted rabbit.
    Myers S; Zipser R; Needleman P
    Adv Prostaglandin Thromboxane Res; 1980; 7():1171-3. PubMed ID: 7369026
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of eicosanoids in the pathogenesis of hemolytic uremic syndrome.
    Benigni A; Remuzzi G
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):75-9. PubMed ID: 7972269
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular activation by thromboxane A2 and other eicosanoids.
    Reilly M; Fitzgerald GA
    Eur Heart J; 1993 Dec; 14 Suppl K():88-93. PubMed ID: 8131796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxanes as mediators of cardiovascular disease states.
    Lefer AM; Smith JB
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():473-5. PubMed ID: 2936146
    [No Abstract]   [Full Text] [Related]  

  • 20. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():168-71. PubMed ID: 2526465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.